As of 2024-12-14, the Fair Value of Vicore Pharma Holding AB (VICO.ST) is -4.26 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.78 SEK, the upside of Vicore Pharma Holding AB is -154.81%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -93.08 | -146.86 | -296.48 | -288.42 | -310.94 | -227.16 |
| YoY growth | -329.33% | -57.77% | -101.88% | 2.72% | -7.81% | -98.82% |
| Market Cap (mil) | 1,825.02 |
| P/E | |
| Forward P/E |
| EPS | -0.85 |
| Avg earnings growth rate | -98.82% |
| TTM earnings | -200.06 |